{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:59:07Z","timestamp":1791644347572,"version":"4.3.4"},"reference-count":83,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Angiology"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Endocan (endothelial cell-specific molecule 1, ESM-1), is a proteoglycan produced by the vascular endothelium that modulates cellular functions such as adhesion, migration, and proliferation. Elevated serum endocan levels are associated with autoimmune and inflammatory disorders, acting as a marker of endothelial activation and dysfunction. This brief overview considers endocan\u2019s role in HTN, cirrhosis, diabetes, peripheral arterial disease (PAD), coronavirus Disease 2019 (COVID-19), erectile dysfunction (ED), and psoriasis vulgaris. Data were gathered from research reporting endocan levels, illness markers, and clinical outcomes. Elevated endocan levels are associated with endothelial dysfunction, which contributes to diabetes complications and associated with vascular endothelial growth factor A (VEGF-A) activation. In HTN, endocan promotes inflammatory signaling and lymphocyte infiltration. In liver disease, particularly cirrhosis, elevated levels correlate with hepatic fibrosis and poor prognosis. PAD patients show raised endocan correlating with disease severity. COVID-19 studies suggest coronavirus induces endotheliitis. In ED, higher endocan levels are linked with endothelial dysfunction and impaired vascular reactivity, serving as a potential biomarker for vascular-related ED. In psoriasis vulgaris, endocan levels correlate with disease severity and cardiovascular risk. The present brief overview supports that monitoring endocan levels may improve treatment and prognosis. Further research is required to define its clinical potential.<\/jats:p>","DOI":"10.1177\/00033197251356576","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T12:57:50Z","timestamp":1753189070000},"page":"799-807","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Endocan, a Potential Biomarker of Endothelial Dysfunction: A Brief Overview"],"prefix":"10.1177","volume":"77","author":[{"given":"Megha","family":"Bidlan","sequence":"first","affiliation":[{"name":"Ch. Devi Lal College of Pharmacy, Bhagwangarh, Jagadhri, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8869-5833","authenticated-orcid":false,"given":"Mohit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Ch. Devi Lal College of Pharmacy, Bhagwangarh, Jagadhri, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Bhargava","sequence":"additional","affiliation":[{"name":"Ch. Devi Lal College of Pharmacy, Bhagwangarh, Jagadhri, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrinda","family":"Goel","sequence":"additional","affiliation":[{"name":"Ch. Devi Lal College of Pharmacy, Bhagwangarh, Jagadhri, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[{"name":"Ch. Devi Lal College of Pharmacy, Bhagwangarh, Jagadhri, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S118692"},{"key":"e_1_3_2_3_2","first-page":"705027","article-title":"Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan","volume":"1","author":"Delehedde M","year":"2013","unstructured":"Delehedde M, Devenyns L, Maurage CA, Viv\u00e8s RR. Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol. 2013;1:705027.","journal-title":"Int J Cell Biol"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwq100"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.34.20458"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.144891"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000025758"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1805"},{"issue":"1","key":"e_1_3_2_9_2","article-title":"On type 1 diabetesmellituspathogenesis","volume":"7","author":"Paschou SA","year":"2018","unstructured":"Paschou SA, Papadopoulou-Marketou N, Chrousos GP, Kanaka-Gantenbein C. On type 1 diabetesmellituspathogenesis. Endocr Connect. 2018;7(1):R38-R46.","journal-title":"Endocr Connect"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10081306"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/0003319715616240"},{"issue":"9","key":"e_1_3_2_12_2","first-page":"823","article-title":"Systematic review of endocan as a potential biomarker of COVID-19","volume":"74","author":"Khalaji A","year":"2023","unstructured":"Khalaji A, Amirkhani N, Sharifkashani S, et al. Systematic review of endocan as a potential biomarker of COVID-19. Angiology. 2023:;74(9):823-832.","journal-title":"Angiology"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0959-9673.2004.390am.x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000198525.82124.74"},{"key":"e_1_3_2_15_2","volume-title":"Basic Immunology: Functions and Disorders of the Immune System","author":"Abbas AK","year":"2010","unstructured":"Abbas AK, Lichtman AH. Basic Immunology: Functions and Disorders of the Immune System. Saunders\/Elsevier; 2010."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-270819"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-123810"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1911"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2006.05.010"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-156331"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184411"},{"issue":"3","key":"e_1_3_2_22_2","first-page":"243","article-title":"Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects","volume":"33","author":"Masola V","year":"2014","unstructured":"Masola V, Zaza G, Onisto M, Lupo A, Gambaro G. Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. Int Angiol. 2014;33(3):243-254.","journal-title":"Int Angiol"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2019.08.012"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/0003319717740781"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S40172"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.32.2.S64"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0119"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.102992"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2018.79488"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2012.0011"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/6.7.283S"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001680"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.681304"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00012.2007"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12440"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1159\/000350064"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-233"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000084503.91330.49"},{"issue":"3","key":"e_1_3_2_39_2","first-page":"211","article-title":"Circulating resistin levels in patients with left ventricular diastolic dysfunction and the metabolic syndrome","volume":"110","author":"Jung C","year":"2006","unstructured":"Jung C, Gerdes N, Fritzenwanger M, Figulla HR. Circulating resistin levels in patients with left ventricular diastolic dysfunction and the metabolic syndrome. Clin Sci (Lond). 2006;110(3):211-216.","journal-title":"Clin Sci (Lond)"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.227"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.2001.280.4.C719"},{"key":"e_1_3_2_42_2","first-page":"3534042","article-title":"Endocan: a biomarker for hepatosteatosis in patients with metabolic syndrome","volume":"1","author":"Erman H","year":"2020","unstructured":"Erman H, Beydogan E, Cetin SI, Boyuk B. Endocan: a biomarker for hepatosteatosis in patients with metabolic syndrome. Mediators Inflamm. 2020;1:3534042.","journal-title":"Mediators Inflamm"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02579.x"},{"key":"e_1_3_2_44_2","author":"Zierow J.","year":"2018","unstructured":"Zierow J. Investigation of Liver Sinusoidal Endothelial Cells-Characterisation and Application of New Transgenic Mouse Models. Doctoral dissertation; 2018.","journal-title":"Investigation of Liver Sinusoidal Endothelial Cells-Characterisation and Application of New Transgenic Mouse Models"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24485"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21802"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.2040-4603.2015.tb00660.x"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2302073"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.798699"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1177\/0003319714548870"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.2174\/18756212MTA1oOTYh3"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1177\/0003319719828911"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13121669"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.2174\/138161212802481237"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2017.10.022"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom13081251"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1177\/00033197231166492"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61040577"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-022-00998-0"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.320460"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25053042"},{"issue":"1","key":"e_1_3_2_62_2","article-title":"SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives","volume":"3","author":"Giordo R","year":"2021","unstructured":"Giordo R, Paliogiannis P, Mangoni AA, Pintus G. SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives. Vasc Biol. 2021;3(1):R15-R23.","journal-title":"Vasc Biol"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1177\/1557988319893889"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.09.013"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12525"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(98)00147-8"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.107.1.321"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.02.012"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00337.2019"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvq105"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom12040542"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2003.18.2.65"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefroe.2015.05.003"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2012.06.010"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006121304"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1177\/0003319715585664"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2016.1229966"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.150409"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.145094"},{"issue":"4","key":"e_1_3_2_80_2","article-title":"Lymphocyte responses exacerbate angiotensin II-dependent hypertension","volume":"298","author":"Crowley SD","year":"2010","unstructured":"Crowley SD, Song YS, Lin EE, Griffiths R, Kim HS, Ruiz P. Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am J Physiol-Regulat Integr Compar Physiol. 2010;298(4):R1089-R1097.","journal-title":"Am J Physiol-Regulat Integr Compar Physiol"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2012007500058"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2014.04.004"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/153805"},{"issue":"4","key":"e_1_3_2_84_2","first-page":"57","article-title":"The role of endocan in the development of hepatocellular carcinoma","volume":"4","author":"Zhou XH","year":"2016","unstructured":"Zhou XH, Lai X, Mu D, Gong JP, Yin QG. The role of endocan in the development of hepatocellular carcinoma. Am J Cancer Prev. 2016;4(4):57-63.","journal-title":"Am J Cancer Prev"}],"container-title":["Angiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00033197251356576","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00033197251356576","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00033197251356576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:51:57Z","timestamp":1782251517000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00033197251356576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":83,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1177\/00033197251356576"],"URL":"https:\/\/doi.org\/10.1177\/00033197251356576","relation":{},"ISSN":["0003-3197","1940-1574"],"issn-type":[{"value":"0003-3197","type":"print"},{"value":"1940-1574","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]}}}